Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $6.46M | 0.01% |
264,159
+100,908
| +62% | +$2.43M |
|
1352
Kamada
KMDA
$420M
| $6.45M | 0.01% |
832,005
+23,700
| +3% | +$161K |
|
1353
First Financial Corp
THFF
$973M
| $6.44M | 0.01% |
118,773
+26,400
| +29% | +$1.31M |
|
1354
iShares Silver Trust
SLV
$31.4B
| $6.43M | 0.01% |
196,000
+117,200
| +149% | +$3.58M |
|
1355
Puma Biotechnology
PBYI
$452M
| $6.43M | 0.01% |
1,874,713
+45,500
| +2% | +$145K |
|
1356
Encompass Health
EHC
$12.2B
| $6.43M | 0.01% |
52,400
+1,500
| +3% | +$171K |
|
1357
Jones Lang LaSalle
JLL
$16.9B
| $6.42M | 0.01% |
25,089
+4,300
| +21% | +$986K |
|
1358
Bridgewater Bancshares
BWB
$622M
| $6.42M | 0.01% |
403,247
+52,500
| +15% | +$769K |
|
1359
Mesa Laboratories
MLAB
$632M
| $6.41M | 0.01% |
68,027
+59,827
| +730% | +$6.57M |
|
1360
Kewaunee Scientific
KEQU
$104M
| $6.4M | 0.01% |
109,011
+10,800
| +11% | +$401K |
|
1361
Murphy Oil
MUR
$4.98B
| $6.4M | 0.01% |
284,309
-3,091
| -1% | -$68.9K |
|
1362
Shore Bancshares
SHBI
$798M
| $6.39M | 0.01% |
406,315
+10,300
| +3% | +$145K |
|
1363
Nektar Therapeutics
NKTR
$2.56B
| $6.38M | 0.01% |
247,060
-66,392
| -21% | -$745K |
|
1364
Tandem Diabetes Care
TNDM
$1.62B
| $6.38M | 0.01% |
342,327
+56,200
| +20% | +$1.11M |
|
|
LINE
1365
Lineage Inc
LINE
$9.79B
| $6.38M | 0.01% |
146,569
-252,631
| -63% | -$12.2M |
|
1366
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.12B
| $6.37M | 0.01% |
124,000
+104,200
| +526% | +$5.32M |
|
1367
Simmons First National
SFNC
$3.46B
| $6.35M | 0.01% |
335,005
+62,848
| +23% | +$1.18M |
|
1368
Intellia Therapeutics
NTLA
$1.68B
| $6.35M | 0.01% |
+676,900
| New | +$5.56M |
|
1369
Federal Signal
FSS
$7.54B
| $6.34M | 0.01% |
59,600
-21,200
| -26% | -$1.89M |
|
1370
VanEck Gold Miners ETF
GDX
$26.9B
| $6.31M | 0.01% |
121,300
+28,800
| +31% | +$1.43M |
|
|
CIO
1371
DELISTED
City Office REIT
CIO
| $6.31M | 0.01% |
1,182,415
-73,600
| -6% | -$369K |
|
1372
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.48B
| $6.31M | 0.01% |
131,890
+101,490
| +334% | +$4.81M |
|
1373
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.18B
| $6.31M | 0.01% |
141,200
+87,319
| +162% | +$3.88M |
|
1374
US Physical Therapy
USPH
$1.23B
| $6.29M | 0.01% |
80,423
-4,900
| -6% | -$361K |
|
1375
Ally Financial
ALLY
$13.6B
| $6.29M | 0.01% |
+161,400
| New | +$5.59M |
|
Similar funds
Jim Simons's Q2 2025 Portfolio in Review
As of Q2 2025, Jim Simons held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Jim Simons added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Jim Simons's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Jim Simons fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Jim Simons's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Jim Simons opened 612 new positions and closed 496 in Q2 2025.
- Jim Simons's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.